The research team of Prof. Jiancheng Wang developed a type of nanovesicles derived from engineered DC-like M1 macrophage for enhancing tumor immunotherapy
State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center
State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center
State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center. The research team of Prof. Jiancheng Wang developed a type of nanovesicles derived from engineered DC-like M1 macrophage for enhancing tumor immunotherapy[J]. Journal of Chinese Pharmaceutical Sciences, 2026, 35(4): 404-404.
>
>